journal
Journals Journal of Pharmacology and Ex...

Journal of Pharmacology and Experimental Therapeutics

https://read.qxmd.com/read/39379148/new-potential-ligand-receptor-axis-involved-in-tissue-repair-as-therapeutic-targets-in-progressive-multiple-sclerosis
#1
JOURNAL ARTICLE
Eugenio Antonio Carrera Silva, Jorge Correale, Carla Rothlin, Juan Manuel Ortiz Wilczyñski
Progressive multiple sclerosis (PMS) represents the worsening phase of the disease by accumulative neurodegeneration and disability, mainly refractory to current treatments. The therapeutic options remain challenging based partially on the lack of understanding of the pathogenic mechanisms but also because the early dogma was centered on neuroinflammation, overshadowing the critical role of the tissue repair process. The tissue repair target should necessarily start early in disease development and PMS should combine anti-inflammatory and neuroprotective therapeutic strategies...
October 8, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39379147/ch6824025-potent-and-selective-ddr1-inhibitor-reduces-kidney-fibrosis-in-uuo-mice
#2
JOURNAL ARTICLE
Yukari Yasui, Takeshi Murata, Yoshinori Tsuboi, Atsuko Murai, Naoshi Horiba
Discoidin domain receptor 1 (DDR1) is a collagen receptor with tyrosine kinase activity, and its expression is enhanced in various disease conditions. Although previous research suggests that DDR1 contributes to renal disease progression, DDR1 inhibitors for renal fibrosis have yet to be developed. In this study, we used unilateral ureteral obstruction (UUO) mice to investigate whether CH6824025, a strong and selective DDR1 phosphorylation inhibitor, can improve renal fibrosis. Furthermore, we performed 10x Visium spatial transcriptomics (ST) analysis on the kidney...
October 8, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39379146/-pharmacological-effects-of-small-molecule-bcr-abl-tyrosine-kinase-inhibitors-on-platelet-function
#3
JOURNAL ARTICLE
Yiheng Zhang, Chih-Jen Yang, Alexander R Melrose, Jiaqing Pang, Kirrali Schofield, Serena D Song, Iván Parra-Izquierdo, Tony J Zheng, Joseph P Lyssikatos, Stefan D Gross, Joseph J Shatzel, Owen J T McCarty, Joseph E Aslan
Tyrosine kinase inhibitors (TKIs) targeting the BCR-ABL fusion protein, such as imatinib (Gleevec), have revolutionized targeted cancer therapies. However, drug resistance and side effects, particularly those affecting hemostasis, continue to pose significant challenges for TKI therapies. As tyrosine kinases serve pivotal roles in platelet hemostatic function, we investigated the potential impact of both established and emerging ABL TKIs on human platelet activities ex vivo Our study included standard-of-care agents (e...
October 8, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39379145/-the-protective-effect-of-irisin-against-hemorrhagic-injury-is-mediated-by-pi3k-and-p38-pathways-in-hemorrhage-resuscitation
#4
JOURNAL ARTICLE
Huai Wen, Naohiro Yano, Thomas Zhao, Lei Wei, Ting C Zhao
The objective of this study is to investigate whether PI3kinase (PI3K) and p38 mitogen-activated kinase contributes to the protection of irisin during hemorrhage/resuscitation. Experimental groups were divided by receiving the different treatments during resuscitation: I ) Hemorrhage: Adult male CD-1 mice were subjected to hemorrhage at a mean arterial blood pressure of 35~45 mmHg for 60 min followed by 120 min of resuscitation (n=13); II ) Hemorrhage + Irisin: receiving irisin (5µg/kg) (n=13); III ) Hemorrhage + Irisin + PI3K inhibitor: receiving both Ly294002 (1mg/kg, i...
October 8, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39379144/metformin-in-overcoming-enzalutamide-resistance-in-castration-resistant-prostate-cancer
#5
JOURNAL ARTICLE
Kendall Simpson, Derek B Allison, Daheng He, Jinpeng Liu, Chi Wang, Xiaoqi Liu
Androgen deprivation is the standard treatment for prostate cancer (PCa) patients. However, the disease eventually progresses as castration-resistant PCa (CRPC). Enzalutamide, an AR inhibitor, is a typical drug to treating CRPC and due to continuous reliance on the drug, can lead to Enzalutamide-resistance (ENZ-r). This highlights the necessity for developing novel therapeutic targets to combat the gain of resistance. Metformin has been recently investigated for its potential anti-tumorigenic effects in many cancer types...
October 8, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39379143/the-protective-effect-of-amitriptyline-on-experimental-colitis-through-inhibiting-tlr4-md2-signaling-pathway
#6
JOURNAL ARTICLE
Chengcheng Zeng, Qingqing Zhu, Wu Peng, Chen Huang, Huiting Chen, Hongli Huang, Yongjian Zhou, Chong Zhao
Amitriptyline, a pleiotropic tricyclic antidepressant, possesses anti-oxidant and anti-inflammatory properties. Despite its diverse benefits, the specific effects of amitriptyline on IBD are not yet well defined. To explore this, we utilized a DSS-induced colitis model to examine the anti-inflammatory effects of amitriptyline and the underlying mechanisms by which it operates. Our research revealed that amitriptyline is effective in alleviating several pathological manifestations associated with colitis. This includes improvements in body weight retention, reductions in DAI, lessening of colon length shortening, and repair of colonic mucosal damage...
October 8, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39379142/cosmic-database-and-structural-modeling-analysis-of-cyp2d6-mutations-in-human-cancers
#7
JOURNAL ARTICLE
Kennedy Kuchinski, Nathaniel King, Julia Driggers, Kylie Lawson, Martin Vo, Shayne Skrtic, Connor Slattery, Rebecca Lane, Emma Simone, Stephen A Mills, Wilber Escorcia, Hanna Wetzel
Single nucleotide polymorphisms (SNPs) in cytochrome P450 (CYP450) enzymes alter the metabolism of a variety of drugs. Numerous medications, including chemotherapies, are metabolized by CYP450 enzymes, making the expression of this suite of enzymes in tumor cells relevant to prescription regimens for cancer patients. We analyzed the characteristics of mutations of the CYP2D6 enzymes in cancer patients obtained from the Catalogue of Somatic Mutations in Cancer (COSMIC), including mutation type, age of the patient, tissue type, and histology...
October 8, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39322416/understanding-cisplatin-pharmacokinetics-and-toxicodynamics-to-predict-and-prevent-kidney-injury
#8
JOURNAL ARTICLE
Lauren E Thompson, Melanie S Joy
Cisplatin is a common platinum-based chemotherapeutic that induces acute kidney injury (AKI) in about 30% of patients. Pharmacokinetic/toxicodynamic (PKTD) models of cisplatin-induced AKI have been used to understand risk factors and evaluate potential mitigation strategies. While both traditional clinical biomarkers of kidney function [e.g. serum creatinine (SCr), blood urea nitrogen (BUN), estimated glomerular filtration rate (eGFR), and creatinine clearance (CrCl)] and newer subclinical biomarkers of kidney injury [e...
September 25, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39304350/-contrasting-the-reinforcing-effects-of-the-novel-dopamine-transport-inhibitors-jjc8-088-and-jjc8-091-in-monkeys-potential-translation-to-medication-assisted-treatment
#9
JOURNAL ARTICLE
Mia I Allen, Omeed Rahimi, Bernard N Johnson, Jianjing Cao, Amy Hauck Newman, Michael A Nader
Despite considerable efforts, there remains no FDA-approved medications for cocaine use disorder (CUD). One strategy to mitigate cocaine craving and relapse is to elevate dopamine (DA). The DA transport inhibitor and releaser d -amphetamine has been shown to decrease cocaine self-administration (SA), although it has abuse liability. Recently, several modafinil analogues reduced cocaine SA in rats and monkeys, including JJC8-088, characterized as "cocaine like" in rats, and JJC8-091, characterized as "atypical" and not SA by rats...
September 20, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39304349/-efficacy-of-fluoxetine-and-r-s-ketamine-in-attenuating-conditioned-fear-behaviors-in-male-mice
#10
JOURNAL ARTICLE
Megan Wells, Jan Hoffmann, Autumn Stage, Isabella Enger, Jayme Pomper, Lily Briggs, Amber LaCrosse
Post-traumatic stress disorder (PTSD) is caused by exposure to a traumatic or stressful event. Symptoms related to this disorder include persistent re-experiencing of memories and fear generalization. Current pharmacological treatments for PTSD are insufficient, with fewer than 30% of patients reporting symptom remission. This study aims to determine the efficacy of acute ( R,S) ketamine and chronic fluoxetine (FLX) in reducing fear memory and fear generalization. In rodents, fear conditioning (FC) is commonly used in the literature to induce behaviors related to symptoms of PTSD, and the open field test (OFT) can assess anxiety and fear generalization behaviors during the exploration of a novel environment...
September 20, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39284628/-nonclinical-profile-of-pf-06952229-mdv6058-a-novel-tgf%C3%AE-ri-activin-like-kinase-5-alk-5-inhibitor-supports-clinical-evaluation-in-cancer
#11
JOURNAL ARTICLE
Mausumee Guha, Stephane Thibault, Son Pham, Sebastian Bernales, Rama Pai, Francisco J Herrera, Theodore R Johnson, Allison Vitsky, Tina Fernando, Martin Finkelstein
The development of TGFβR inhibitors (TGFβRi) as new medicines have been affected by cardiac valvulopathy and arteriopathy toxicity findings in nonclinical toxicology studies. PF-06952229 (MDV6058) selected using rational drug design is a potent and selective TGFβRI inhibitor (TGFβRIi) with a relatively clean off-target selectivity profile and good pharmacokinetic properties across species. PF-06952229 inhibited clinically translatable phospho-SMAD2 biomarker ({greater than or equal to}60%) in human and cynomolgus monkey peripheral blood mononuclear cells, as well as in mouse and rat splenocytes...
September 16, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39284627/alternative-reinforcers-enhance-the-effects-of-opioid-antagonists-but-not-agonists-on-oxycodone-choice-self-administration-in-nonhuman-primates
#12
JOURNAL ARTICLE
Fernando B de Moura, Stephen J Kohut
Clinical reports suggest that the most effective strategies for managing opioid use disorder comprise a comprehensive treatment program of both pharmacological and non-pharmacological approaches. However, the conditions under which these combinations are most effective are not well characterized. This study examined whether the presence of an alternative reinforcer could alter the efficacy of FDA-approved opioid antagonist or agonist medications, as well as the non-opioid flumazenil, in decreasing oxycodone choice self-administration in nonhuman primates...
September 16, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39284626/-factors-influencing-the-central-nervous-system-cns-distribution-of-the-atr-inhibitor-elimusertib-bay1895344-implications-for-the-treatment-of-cns-tumors
#13
JOURNAL ARTICLE
Sneha Rathi, Ann C Mladek, Ju-Hee Oh, Sonja Dragojevic, Danielle M Burgenske, Wenjuan Zhang, Surabhi Talele, Wenqiu Zhang, Katrina K Bakken, Brett L Carlson, Margaret A Connors, Lihong He, Zeng Hu, Jann N Sarkaria, William F Elmquist
Glioblastoma (GBM) is a disease of the whole brain, with infiltrative tumor cells protected by an intact BBB. GBM has a poor prognosis despite aggressive treatment, in part due to lack of adequate drug permeability at the BBB. Standard of care GBM therapies include radiation and cytotoxic chemotherapy that lead to DNA damage. Subsequent activation of DNA damage response (DDR) pathways can induce resistance. Various DDR inhibitors, targeting the key regulators of these pathways such as ataxia telangiectasia mutated and Rad3-related (ATR), are being explored as radio- and chemo-sensitizers...
September 16, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39284625/-identification-of-pyrimidine-structure-based-compounds-as-allosteric-ligands-of-the-dopamine-transporter-as-therapeutic-agents-for-neurohiv
#14
JOURNAL ARTICLE
Ana Catya Jimenez-Torres, Jamison A Hastie, Sarah E Davis, Katherine D Porter, Bin Lei, Omar Moukha-Chafiq, Sixue Zhang, Theresa H Nguyen, Subramaniam Ananthan, Corinne E Augelli-Szafran, Jun Zhu
The disruption of dopamine neurotransmission by the HIV-1 Transactivator of transcription (Tat) during HIV-1 infection has been linked to the development of neurocognitive disorders, even under combined antiretroviral therapy (cART) treatment. We have demonstrated that SRI-32742, a novel allosteric modulator of dopamine (DA) transporter (DAT), attenuates cocaine- and Tat-binding to DAT, alleviates Tat-induced cognitive deficits and potentiation of cocaine reward in inducible Tat transgenic mice. The current study determined the in vitro pharmacological profile of SRI-32743 and its optimized second-generation analogs and their effects as allosteric modulators...
September 16, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39284624/first-in-class-mitogen-activated-protein-kinase-p38%C3%AE-mapk-activated-protein-kinase-2-mk2-dual-signal-modulator-with-anti-inflammatory-and-endothelial-stabilizing-properties
#15
JOURNAL ARTICLE
Mohan E Tulapurkar, Kari Ann Shirey, Katerina N Lugkey, Wendy Luo, Ritu Lal, Adam Galan, Omar Mahmoud, Nathaniel McClean, Kiruphagaran Thangaraju, Daniel Cericola, Daniel Lewis, William A Murphy, Steven Fletcher, Alexander D MacKerell, Stefanie N Vogel, Paul Shapiro, Jeffrey D Hasday
We previously identified a small molecule, UM101, predicted to bind to the substrate-binding groove of p38aMitogen-activated Protein Kinase (MAPK) near the binding site of its proinflammatory substrate, MAPK-activated protein kinase (MK2). UM101 exhibited anti-inflammatory, endothelial-stabilizing, and lung-protective effects. To overcome its limited aqueous solubility and p38a binding affinity, we designed an analog of UM101, GEn-1124, with improved aqueous solubility, stability, and p38a binding affinity...
September 16, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39284623/evaluating-the-potential-for-psilocybin-as-a-treatment-for-post-traumatic-stress-disorder
#16
JOURNAL ARTICLE
Claire E Miller, Phillip R Zoladz
Post-traumatic stress disorder (PTSD) is a debilitating psychiatric condition that develops following exposure to a traumatic event. Individuals with this condition experience numerous physiological and behavioral alterations, including intrusive memories, avoidance of trauma-related stimuli, heightened anxiety, hypervigilance, impaired cognition, elevated resting heart rate and blood pressure, and altered neuroendocrine function, to name a few. In most patients, currently available pharmacological and psychological treatments are insufficient to alleviate the array of symptoms associated with the disorder...
September 16, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39284622/-sensory-motor-neuropathy-in-mfn2-t105m-knock-in-mice-and-its-reversal-by-a-novel-piperine-derived-mitofusin-activator
#17
JOURNAL ARTICLE
Jochen Weigele, Lihong Zhang, Antonietta Franco, Etienne Cartier, Gerald W Dorn
Mitochondrial dysfunction is a hallmark of many genetic neurodegenerative diseases, but therapeutic options to reverse mitochondrial dysfunction are limited. While recent studies support the possibility of improving mitochondrial fusion/fission dynamics and motility to correct mitochondrial dysfunction and resulting neurodegeneration in Charcot-Marie-Tooth disease (CMT) and other neuropathies, the clinical utility of reported compounds and relevance of pre-clinical models are uncertain. Here, we describe motor and sensory neuron dysfunction characteristic of clinical CMT type 2A in a CRISPR/Casp-engineered Mfn2 Thr105Met (T105M) mutant knock-in mouse...
September 16, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39179416/-gabapentinoids-increase-the-potency-of-fentanyl-and-heroin-and-decrease-the-potency-of-naloxone-to-antagonize-fentanyl-and-heroin-in-rats-discriminating-fentanyl
#18
JOURNAL ARTICLE
Takato Hiranita, Shawn M Flynn, Amanda K Grisham, Abram E Mijares, Erin N Murphy, Charles P France
Despite a significant decrease in the number of prescriptions for opioids, the opioid crisis continues, fueled in large part by the availability of the phenylpiperadine mu opioid receptor (MOR) agonist fentanyl. In contrast, the number of prescriptions for and the off-label use of gabapentinoids (gabapentin and pregabalin) has increased dramatically with gabapentinoids commonly detected in opioid overdose victims. Although gabapentinoids can decrease the potency of the opioid receptor antagonist naloxone to reverse heroin-induced hypoventilation in male rats, the specificity and nature of interaction between gabapentinoids and MOR agonists and any potential sex difference in those interactions are not well characterized...
August 23, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39179415/kvx-053-a-protein-tyrosine-phosphatase-4a3-inhibitor-ameliorates-sars-cov-2-spike-protein-subunit-1-induced-acute-lung-injury-in-mice
#19
JOURNAL ARTICLE
Pavel A Solopov, Ruben Manuel Luciano Colunga Biancatelli, Tierney Day, Betsy Gregory, Elizabeth R Sharlow, John S Lazo, John D Catravas
The Acute Respiratory Distress Syndrome (ARDS), often preceded by acute lung injury (ALI), is characterized by the accumulation of inflammatory fluid in the lung alveoli, leaky alveolar epithelium and endothelium, and overexpression of pro-inflammatory cytokines. This progression from ALI to ARDS is a major contributor to the high mortality observed in COVID-19 patients. The Spike protein of SARS-CoV-2 binds to lung ACE2 and, in addition to facilitating viral cell entry, it plays an important role in the development of ALI and ARDS, especially in the later phases of COVID-19 as well as long COVID...
August 23, 2024: Journal of Pharmacology and Experimental Therapeutics
https://read.qxmd.com/read/39179414/-significance-of-nitric-oxide-derived-from-the-nitric-oxide-synthases-system-in-cardiovascular-inter-organ-cross-talk
#20
JOURNAL ARTICLE
Masato Tsutsui, Kazuhiro Yatera
Inter-organ cross-talk contributes to the pathogenesis of various disorders, and drug development based on inter-organ cross-talk is attracting attention. The roles of nitric oxide (NO) derived from the NO synthases system (NOSs) in inter-organ cross-talk remain unclear. We have investigated this issue by using our mice deficient in all three NOSs (triple n/i/eNOSs-/- mice). We reported that 2/3 nephrectomized triple n/i/eNOSs-/- mice die suddenly because of early onset of myocardial infarction, suggesting the protective role of NO derived from NOSs in the cross-talk between the kidney and the heart...
August 23, 2024: Journal of Pharmacology and Experimental Therapeutics
journal
journal
23880
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.